Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention

Discovery Medicine

Volumn 20, Issue 109, 2015, Pages 129-135

  Mankia, Kulveer ^a   Emery, Paul ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICITRULLINATED PROTEIN ANTIBODY; FC RECEPTOR; GLYCOPROTEIN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; METHOTREXATE; PROTEIN ANTIBODY; RHEUMATOID FACTOR; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTOANTIBODY;

ALLELE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIUM ADHERENCE; CHRONIC ARTHRITIS; CLINICAL FEATURE; CONTROLLED STUDY; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPHATIC SYSTEM DISEASE; MARGINAL ZONE LYMPHOMA; MOUTH MUCOSA; PERIODONTAL DISEASE; PLASMA CELL; RHEUMATOID ARTHRITIS; RISK FACTOR; SALIVARY GLAND DUCT; SMOKING HABIT; SOFT TISSUE INFLAMMATION; ANIMAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTESTINE; INTESTINE FLORA; LUNG; MICROBIOLOGY; MUCOSA; PATHOLOGY; SMOKING; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE TOLERANCE; INTESTINES; LUNG; MOUTH MUCOSA; MUCOUS MEMBRANE; RISK FACTORS; SMOKING; T-LYMPHOCYTES;

EID: 84944460785     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Abou-Raya A, Abou-Raya S, Abu-Elkheir H. Periodontal disease and rheumatoid arthritis: is there a link? Scand J Rheumatol 34(5):408-410, 2005.
2. Albandar JM, Streckfus CF, Adesanya MR, Winn DM. Cigar, pipe, and cigarette smoking as risk factors for periodontal disease and tooth loss. J Periodontol 71(12):1874-1881, 2000.
3. Arlestig L, Mullazehi M, Kokkonen H, Rocklov J, Ronnelid J, Dahlqvist SR. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann Rheum Dis 71(6):825-829, 2012.
4. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 160(1):403-409, 1998.
5. Barra L, Scinocca M, Saunders S, Bhayana R, Rohekar S, Racape M, Coles R, Cairns E, Bell DA. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum 65(6):1439-1447, 2013.
6. Biyikoglu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoglu E, Kinane DF. Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int 33(10):2607-2616, 2013.
7. Bonfil JJ, Dillier FL, Mercier P, Reviron D, Foti B, Sambuc R, Brodeur JM, Sedarat C. A "case control" study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol 26(2):77-84, 1999.
8. Brandtzaeg P. Regionalized immune function of tonsils and adenoids. Immunol Today 20(8):383-384, 1999.
9. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 293(1):3-15, 2003.
10. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins. Scand J Haematol Suppl 12:3-83, 1970.
11. Brink M, Hansson M, Mathsson L, Jakobsson PJ, Holmdahl R, Hallmans G, Stenlund H, Ronnelid J, Klareskog L, Rantapaa-Dahlqvist S. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum 65(4):899-910, 2013.
12. Crabbe PA, Carbonara AO, Heremans JF. The Normal Human Intestinal Mucosa as a Major Source of Plasma Cells Containing Gamma-a-Immunoglobulin. Lab Invest 14:235-248, 1965.
13. De Smit M, Van De Stadt LA, Janssen KM, Doornbos-Van Der Meer B, Vissink A, Van WinkelhoffAJ, Brouwer E, Westra J, Van Schaardenburg D. Antibodies against Porphyromonas gingivalis in seropositive arthralgia patients do not predict development of rheumatoid arthritis. Ann Rheum Dis 73(6):1277-1279, 2014.
14. Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, Graves DT. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 28(3):233-240, 2001.
15. Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, Harrington AR, Kolfenbach JR, Striebich CC, Pham QN, Strickland CD, Petersen BD, Parish MC, Derber LA, Norris JM, Holers VM, Deane KD. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 64(6):1756-1761, 2012.
16. Dissick A, Redman RS, Jones M, Rangan BV, Reimold A, Griffiths GR, Mikuls TR, Amdur RL, Richards JS, Kerr GS. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol 81(2):223-230, 2010.
17. Erciyas K, Sezer U, Ustun K, Pehlivan Y, Kisacik B, Senyurt SZ, Tarakcioglu M, Onat AM. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis. 19(4):394-400, 2013.
18. Fischer A, Solomon JJ, Du Bois RM, Deane KD, Olson AL, Fernandez-Perez ER, Huie TJ, Stevens AD, Gill MB, Rabinovitch AM, Lynch DA, Burns DA, Pineiro IS, Groshong SD, Duarte Achcar RD, Brown KK, Martin RJ, Swigris JJ. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 106(7):1040-1047, 2012.
19. Gerlag DM, Raza K, Van Baarsen LG, Brouwer E, Buckley CD, Burmester GR, Gabay C, Catrina AI, Cope AP, Cornelis F, Dahlqvist SR, Emery P, Eyre S, Finckh A, Gay S, Hazes JM, Van Der Helm-Van Mil A, Huizinga TW, Klareskog L, Kvien TK, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 71(5):638-641, 2012.
20. Harvey GP, Fitzsimmons TR, Dhamarpatni AA, Marchant C, Haynes DR, Bartold PM. Expression of peptidylarginine deiminase-2 and-4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res 48(2):252-261, 2013.
21. Hendler A, Mulli TK, Hughes FJ, Perrett D, Bombardieri M, Houri-Haddad Y, Weiss EI, Nissim A. Involvement of autoimmunity in the pathogenesis of aggressive periodontitis. J Dent Res 89(12):1389-1394, 2010.
22. Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, Van Der Woude D, Markland J, Robinson D, Elias B, Newkirk M, Toes RM, Huizinga TW, El-Gabalawy HS. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 37(6):1105-1112, 2010.
23. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54(1):38-46, 2006.
24. Koren O, Knights D, Gonzalez A, Waldron L, Segata N, Knight R, Huttenhower C, Ley RE. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol 9(1):e1002863, 2013.
25. Lappin DF, Apatzidou D, Quirke AM, Oliver-Bell J, Butcher JP, Kinane DF, Riggio MP, Venables P, Mcinnes IB, Culshaw S. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol 40(10):907-915, 2013.
26. Lard LR, Visser H, Speyer I, Vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, Hazes JM. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111(6):446-451, 2001.
27. Lederberg J. Infectious history. Science 288(5464):287-293, 2000.
28. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 108(Suppl 1):4615-4622, 2011.
29. Liu X, Zou Q, Zeng B, Fang Y, Wei H. Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol 67(2):170-176, 2013.
30. Macpherson AJ, Geuking MB, Mccoy KD. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115(2):153-162, 2005.
31. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4(6):478-485, 2004.
32. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67(10):1488-1492, 2008.
33. Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B, Miossec P. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis 65(7):905-909, 2006.
34. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107-118, 2005.
35. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620-625, 2008.
36. Mcgraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 67(7):3248-3256, 1999.
37. Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, Markt J, Mcgowan D, Kerr GS, Redman RS, Reimold A, Griffiths G, Beatty M, Gonzalez SM, Bergman DA, Hamilton BC, 3rd, Erickson AR, Sokolove J, Robinson WH, Walker C, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 66(5):1090-1100, 2014.
38. Mikuls TR, Thiele GM, Deane KD, Payne JB, O'dell JR, Yu F, Sayles H, Weisman MH, Gregersen PK, Buckner JH, Keating RM, Derber LA, Robinson WH, Holers VM, Norris JM. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 64(11):3522-3530, 2012.
39. Morton AM, Sefik E, Upadhyay R, Weissleder R, Benoist C, Mathis D. Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut. Proc Natl Acad Sci U S A 111(18):6696-6701, 2014.
40. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford, England) 43(7):906-914, 2004.
41. Nesse W, Dijkstra PU, Abbas F, Spijkervet FK, Stijger A, Tromp JA, Van Dijk JL, Vissink A. Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study. J Periodontol 81(11):1622-1628, 2010.
42. Nielen MM, Van Schaardenburg D, Reesink HW, Van De Stadt RJ, Van Der Horst-Bruinsma IE, De Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50(2):380-386, 2004.
43. Ochoa-Reparaz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 3(5):487-495, 2010.
44. Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 35(3):169-174, 2006.
45. Phalipon A, Corthesy B. Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins. Trends Immunol 24(2):55-58, 2003.
46. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118(2):229-241, 2004.
47. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 116(12):3183-3194, 2006.
48. Rantapaa-Dahlqvist S, De Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, Van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48(10):2741-2749, 2003.
49. Reynisdottir G, Karimi R, Joshua V, Olsen H, Hensvold AH, Harju A, Engstrom M, Grunewald J, Nyren S, Eklund A, Klareskog L, Skold CM, Catrina AI. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol (Hoboken, N.J.) 66(1):31-39, 2014.
50. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 28(6):311-318, 2004.
51. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107(27):12204-12209, 2010.
52. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 7(10):569-578, 2011.
53. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2:e01202, 2013.
54. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, Lipuma L, Attur M, Pillinger MH, Weissmann G, Littman DR, Pamer EG, Bretz WA, Abramson SB. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 64(10):3083-3094, 2012.
55. Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, Edison JD, Gilliland WR, Tibshirani RJ, Norris JM, Holers VM, Robinson WH. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PloS One 7(5):e35296, 2012.
56. Stepankova R, Powrie F, Kofronova O, Kozakova H, Hudcovic T, Hrncir T, Uhlig H, Read S, Rehakova Z, Benada O, Heczko P, Strus M, Bland P, Tlaskalova-Hogenova H. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis 13(10):1202-1211, 2007.
57. Svard A, Kastbom A, Sommarin Y, Skogh T. Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis. Immunobiology 218(2):232-237, 2013.
58. Tomasi TB, Jr., Tan EM, Solomon A, Prendergast RA. Characteristics of an Immune System Common to Certain External Secretions. J Exp Med 121:101-124, 1965.
59. Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 35(8):1500-1505, 2008.
60. Van De Sande MG, De Hair MJ, Van Der Leij C, Klarenbeek PL, Bos WH, Smith MD, Maas M, De Vries N, Van Schaardenburg D, Dijkmans BA, Gerlag DM, Tak PP. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 70(5):772-777, 2011.
61. Van Der Linden MP, Le Cessie S, Raza K, Van Der Woude D, Knevel R, Huizinga TW, Van Der Helm-Van Mil AH. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 62(12):3537-3546, 2010.
62. Van Der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, Drijfhout JW, Huizinga TW, Toes RE, Pruijn GJ. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 69(8):1554-1561, 2010.
63. Wade WG. The oral microbiome in health and disease. Pharmacol Res 69(1):137-143, 2013.
64. Willis VC, Demoruelle MK, Derber LA, Chartier-Logan CJ, Parish MC, Pedraza IF, Weisman MH, Norris JM, Holers VM, Deane KD. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 65(10):2545-2554, 2013.
65. Wu HJ, Ivanov, Ii, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32(6):815-827, 2010.
66. Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, Haj Hensvold A, Eklund A, Skold CM, Grunewald J, Malmstrom V, Jakobsson PJ, Ronnelid J, Padyukov L, Zubarev RA, Klareskog L, Catrina AI. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation. Ann Rheum Dis 2014 [epub ahead of print].